Condition: Hepatocarcinoma · Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
The main objectives of this research project concern the identification of microRNAs circulating and of serum metabolites predictive of treatment response in patients with early stage hepatocellular carcinoma undergoing locoregional treatment with thermoablation. In addition, the molecular mechanisms involved in reprogramming will be identified metabolic via bioinformatics analysis and pretreatment liver biopsy analysis and analysis of screening on patient-derived primary lines for personalized therapy.
This description comes directly from the study's public registry record.
Andrea Boccatonda, MD · +39 0512143265 · andrea.boccatonda@aosp.bo.it
Always discuss trial participation with your own doctor first.
| IRCCS Policlinico di Sant'Orsola | Bologna, Emilia-Romagna, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07601464